We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

By LabMedica International staff writers
Posted on 24 Sep 2026

Autoimmune encephalitis can cause memory and behavioral changes, seizures, and altered consciousness, but diagnosis can be challenging because cancers involving the brain and central nervous system may produce similar symptoms and mimic inflammation on imaging and cerebrospinal fluid tests. More...

When antibody testing for autoimmune encephalitis is negative, an underlying tumor may remain undetected. A new diagnostic proposal seeks to address this gap by adding cerebrospinal fluid liquid biopsy to the evaluation of selected patients.

The workflow proposed by University of Kentucky (UK; Lexington, Kentucky) researchers uses cerebrospinal fluid (CSF) liquid biopsy to detect genetic and molecular signs of cancer. Because CSF is often collected by spinal tap during evaluation for autoimmune encephalitis, the approach would add molecular testing to a specimen already obtained as part of the diagnostic workup. It is intended for patients whose findings raise concern that an underlying cancer, rather than autoimmune disease, may be responsible for their symptoms.

The workflow identifies five reasons to consider liquid biopsy: unusual symptoms despite negative antibody tests, unclear MRI findings, lack of response to initial treatment, a current or previous cancer diagnosis, and inflammatory CSF despite negative conventional cancer testing. The described methods include validated, commercially available tests incorporated into National Comprehensive Cancer Network guidelines for several cancers affecting the central nervous system. Some targeted tests can return results within hours.

The proposal cites a multicenter study of autoimmune encephalitis misdiagnosis in which brain tumors accounted for 9.5% of misdiagnoses. Patients in that study waited a median of 16 months for the correct diagnosis, and one in five experienced complications from immunotherapy they did not need. Those figures describe the cited study, not a performance evaluation of the proposed liquid biopsy workflow.

The proposal was published in the Journal of the Neurological Sciences on September 15, 2026. It does not call for liquid biopsy in every patient evaluated for autoimmune encephalitis. Instead, it describes warning signs that could prompt clinicians to broaden the search for an underlying cancer.

"This workflow is designed to save lives. We need to recognize when the underlying problem may be cancer and use the tools available to find what might otherwise be missed," said Jagannadha "Jay" Avasarala, M.D., of the UK College of Medicine Department of Neurology.

Related Links
UK College of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.